Dofetilide
Antiarrhythmic medication / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Dofetilide?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Dofetilide is a class III antiarrhythmic agent.[2] It is marketed under the trade name Tikosyn by Pfizer, and is available in the United States in capsules containing 125, 250, and 500 µg of dofetilide. It is not available in Europe[3] or Australia.[4]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Tikosyn |
AHFS/Drugs.com | Monograph |
MedlinePlus | a601235 |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 96% (oral) |
Protein binding | 60% -70% |
Elimination half-life | 10 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.166.441 |
Chemical and physical data | |
Formula | C19H27N3O5S2 |
Molar mass | 441.56 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Close